News

Technology News

NeuroMetrix Launches Peripheral Neuropathy Test

Thursday, July 07, 2011 5:01:00 AM PDT | VentureDeal Staff
   Waltham, Massachusetts  --  Neurotechnology company NeuroMetrix (NASDAQ: NURO) announced the successful launch of its quantitative test for the evaluation of systemic neuropathies.

Called the NC-stat DPNCheck, the test measures sural nerve conduction velocity and response amplitude, which the company says are standard biomarkers for diabetic peripheral neuropathy.

The company said that the device would be commercially available for evaluations and purchase in September.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.